Literature DB >> 24791887

Metformin inhibits nuclear factor-κB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro.

Junfei Gu1, Shandong Ye2, Shan Wang1, Wenjia Sun1, Yuanyuan Hu1.   

Abstract

BACKGROUND: The renoprotective mechanisms of adenosine monophosphate (AMP)-activated protein kinase (AMPK) agonist - metformin have not been stated clearly. We hypothesized that metformin may ameliorate inflammation via AMPK interaction with critical inflammatory cytokines. The aim of this study was to observe the effects of metformin on expression of nuclear factor-κB (NF-κB), monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule-1 (ICAM-1) and transforming growth factor-beta 1 (TGF-β1) induced by high glucose (HG) in cultured rat glomerular mesangial cells (MCs).
METHODS: MCs were cultured in the medium with normal concentration glucose (group NG, 5.6 mmol/L), high concentration glucose (group HG, 25 mmol/L) and different concentrations of metformin (group M1, M2, M3). After 48-hour exposure, the supernatants and MCs were collected. The expression of NF-κB, MCP-1, ICAM-1, and TGF-β1 mRNA was analyzed by real time polymerase chain reaction. Western blotting was used to detect the expression of AMPK, phospho-Thr-172 AMPK (p-AMPK), NF-κB p65, MCP-1, ICAM-1, and TGF-β1 protein.
RESULTS: After stimulated by HG, the expression of NF-κB, MCP-1, ICAM-1, TGF-β1 mRNA and protein of MCs in group HG increased significantly compared with group NG (P < 0.05). Both genes and protein expression of NF-κB, MCP-1, ICAM-1, TGF-β1 of MCs induced by high glucose were markedly reduced after metformin treatment in a dose-dependent manner (P < 0.05). The expression of p-AMPK increased with the rising of metformin concentration, presenting the opposite trend, while the level of total-AMPK protein was unchanged with exposure to HG or metformin. Conlusion Metformin can suppress the expression of NF-κB, MCP-1, ICAM-1 and TGF-β1 of glomerular MCs induced by high glucose via AMPK activation, which may partly contribute to its reno-protection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24791887

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  13 in total

1.  Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Authors:  Corinna Seliger; Anne-Louise Meyer; Kathrin Renner; Verena Leidgens; Sylvia Moeckel; Birgit Jachnik; Katja Dettmer; Ulrike Tischler; Valeria Gerthofer; Lisa Rauer; Martin Uhl; Martin Proescholdt; Ulrich Bogdahn; Markus J Riemenschneider; Peter J Oefner; Marina Kreutz; Arabel Vollmann-Zwerenz; Peter Hau
Journal:  Cell Cycle       Date:  2016-05-10       Impact factor: 4.534

2.  Metformin Enhances B Cell Function and Antibody Responses of Elderly Individuals With Type-2 Diabetes Mellitus.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Bonnie B Blomberg
Journal:  Front Aging       Date:  2021-07-23

3.  Investigation into the anti-inflammatory properties of metformin in intervertebral disc cells.

Authors:  Rahul Ramanathan; Ayesha Firdous; Qing Dong; Dong Wang; Joon Lee; Nam Vo; Gwendolyn Sowa
Journal:  JOR Spine       Date:  2022-03-10

4.  Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression.

Authors:  Zhong'e Zhou; Yong Tang; Xian Jin; Chengjun Chen; Yi Lu; Liang Liu; Chengxing Shen
Journal:  J Diabetes Res       Date:  2016-09-28       Impact factor: 4.011

5.  Divergent Effects of Metformin on an Inflammatory Model of Parkinson's Disease.

Authors:  Khadija Tayara; Ana M Espinosa-Oliva; Irene García-Domínguez; Afrah Abdul Ismaiel; Antonio Boza-Serrano; Tomas Deierborg; Alberto Machado; Antonio J Herrera; José L Venero; Rocío M de Pablos
Journal:  Front Cell Neurosci       Date:  2018-11-21       Impact factor: 5.505

6.  Influence of high glucose on mesangial cell-derived exosome composition, secretion and cell communication.

Authors:  Antônio da Silva Novaes; Fernanda Teixeira Borges; Edgar Maquigussa; Vanessa Araújo Varela; Marcos Vinicios Salles Dias; Mirian Aparecida Boim
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

Review 7.  Metformin: the updated protective property in kidney disease.

Authors:  Qingjun Pan; Xing Lu; Chunfei Zhao; Shuzhen Liao; Xiaoqun Chen; Fengbiao Guo; Chen Yang; Hua-Feng Liu
Journal:  Aging (Albany NY)       Date:  2020-05-01       Impact factor: 5.682

Review 8.  Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease.

Authors:  Pascual Sanz; José Maria Serratosa; Marina P Sánchez
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 9.  Exercise in a Pill: The Latest on Exercise-Mimetics.

Authors:  Davide Guerrieri; Hyo Youl Moon; Henriette van Praag
Journal:  Brain Plast       Date:  2017-03-28

Review 10.  The Therapeutic Potential of Metformin in Neurodegenerative Diseases.

Authors:  Carola Rotermund; Gerrit Machetanz; Julia C Fitzgerald
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.